- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05969405
Comparison of Prognosis in Endometrial Cancer Treated With Different Surgical Methods: Laparoscopy, Robotic-assisted Laparoscopy and Laparotomy
July 23, 2023 updated by: Sheng-Mou Hsiao, Far Eastern Memorial Hospital
Objective:To compare the clinical outcomes of endometrial cancer patients who received surgerical treatments: Comparisons of robotic-assisted laparoscopic, laparoscopic and laparotomic methods
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
We will review the medical records of clinically uterine-confined endometrial cancer women who received robotic-assisted laparoscopic, laparoscopic or laparotomic methods; and compare their outcomes.
Study Type
Observational
Enrollment (Estimated)
400
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Taipei
-
Banqiao, New Taipei, Taiwan, 22050
- Recruiting
- Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital
-
Contact:
- Sheng-Mou Hsiao, M.D.
- Phone Number: 1818 +886-2-89667000
- Email: smhsiao2@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
endometrial cancer patients
Description
Inclusion Criteria:
- womwn who received endometrial cancer surgical from January 01, 2008 to November 30, 2022 were be reviewed.
Exclusion Criteria:
- Endometrial cancer patients did not undergo surgery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Laparoscopy
Laparoscopic staging group
|
Laparoscopic staging
|
|
Robotic
Robotic staing group
|
Robotic staging
|
|
Laparotomic
Laparotomic group
|
Laparotomic staging
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall survival
Time Frame: 5 years
|
Overall survival
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Progression free survival
Time Frame: 5 years
|
Progression free survival
|
5 years
|
|
length of hospital stay
Time Frame: 2 weeks
|
length of hospital stay
|
2 weeks
|
|
surgical time
Time Frame: 1 day
|
surgical time
|
1 day
|
|
Estimate blood loss
Time Frame: 1 day
|
Estimate blood loss
|
1 day
|
|
lymph node number
Time Frame: 1 day
|
dissected lymph node number
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 7, 2023
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
July 23, 2023
First Submitted That Met QC Criteria
July 23, 2023
First Posted (Actual)
August 1, 2023
Study Record Updates
Last Update Posted (Actual)
August 1, 2023
Last Update Submitted That Met QC Criteria
July 23, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 112002-E
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometrial Cancer
-
Radboud University Medical CenterMaastricht University Medical Center; Erasmus Medical Center; Catharina Ziekenhuis... and other collaboratorsRecruitingEndometrial Cancer Recurrent | Endometrial Cancer Stage III | Endometrial Cancer Stage IVNetherlands
-
Assistance Publique - Hôpitaux de ParisUniversité Montpellier; Ecole d'econmie de Paris (PSE)-Hospinnomics; Université...CompletedEndometrial Cancer Stage I | Endometrial Cancer Stage IIFrance
-
Ain Shams Maternity HospitalNot yet recruitingTreatment Endometrial Cancer
-
Mayo ClinicRecruitingEndometrial Carcinoma | Stage III Endometrial Cancer | Stage IV Endometrial Cancer | Endometrial High Grade Endometrioid Adenocarcinoma | Stage II Endometrial CancerUnited States
-
Batman Training and Research HospitalEskisehir Osmangazi UniversityCompletedGynecologic Cancer | Endometrial Cancer Stage
-
Novartis PharmaceuticalsCompletedAdvanced Endometrial CancerBelgium, France, Italy, Canada, Spain, Australia, Germany, United States, Japan, Brazil, Singapore, Russian Federation, Poland
-
Rambam Health Care CampusCompletedSerous Papillary Endometrial CancerIsrael
-
Samsung Medical CenterRecruitingEndometrial Cancer Stage IKorea, Republic of
-
Duke UniversityDuke Cancer InstituteCompleted
-
Far Eastern Memorial HospitalCompletedOutcome of Endometrial CancerTaiwan
Clinical Trials on Laparoscopic staging
-
Asan Medical CenterCompletedEndometrial CancerKorea, Republic of
-
Peking UniversityCompletedGastric Cancer | Peritoneal MetastasesChina
-
Tianjin Medical University Cancer Institute and...The First Affiliated Hospital with Nanjing Medical University; Zhejiang Cancer... and other collaboratorsEnrolling by invitationGastric Adenocarcinoma | Gastric Cancer (GC)China
-
National Cancer Center, KoreaUnknownPancreatic CancerKorea, Republic of
-
Charite University, Berlin, GermanyDeutsche Krebshilfe e.V., Bonn (Germany); Arbeitsgemeinschaft Radiologische...Unknown
-
Peking UniversityShanxi Province Cancer Hospital; The First Affiliated Hospital of Nanchang... and other collaboratorsUnknownGastric Cancer | Neoadjuvant Therapy | Gastric Cancer Stage | CTChina
-
University Hospital, GhentLeiden University Medical CenterCompletedCarcinoma, Non-Small-Cell LungBelgium, Netherlands, United Kingdom
-
Ain Shams Maternity HospitalNot yet recruitingTreatment Endometrial Cancer
-
Chongqing University Cancer HospitalRecruitingLocally Advanced Cervical CancerChina
-
National Cancer Institute, NaplesRecruiting